Literature DB >> 18353650

Activating the ubiquitin family: UBA6 challenges the field.

Marcus Groettrup1, Christiane Pelzer, Gunter Schmidtke, Kay Hofmann.   

Abstract

Since its discovery in 1981, ubiquitin-activating enzyme 1 was thought to be the only E1-type enzyme responsible for ubiquitin activation. Recently, a relatively uncharacterized E1 enzyme, designated ubiquitin-like modifier activating enzyme 6, was also shown to activate ubiquitin. Ubiquitin-activating enzyme 1 and ubiquitin-like modifier activating enzyme 6 are both essential proteins, and each uses a different spectrum of ubiquitin-conjugating (E2) enzymes. Ubiquitin-like modifier activating enzyme 6 activates not only ubiquitin, but also the ubiquitin-like modifier FAT10 (human leukocyte antigen F-associated transcript 10), which, similarly to ubiquitin, serves as a signal for proteasomal degradation. This new layer of regulation in ubiquitin activation markedly increases the versatility of the ubiquitin conjugation system.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18353650     DOI: 10.1016/j.tibs.2008.01.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  43 in total

Review 1.  SCF ubiquitin ligase-targeted therapies.

Authors:  Jeffrey R Skaar; Julia K Pagan; Michele Pagano
Journal:  Nat Rev Drug Discov       Date:  2014-11-14       Impact factor: 84.694

2.  USE1 is a bispecific conjugating enzyme for ubiquitin and FAT10, which FAT10ylates itself in cis.

Authors:  Annette Aichem; Christiane Pelzer; Sebastian Lukasiak; Birte Kalveram; Paul W Sheppard; Neha Rani; Gunter Schmidtke; Marcus Groettrup
Journal:  Nat Commun       Date:  2010-05-04       Impact factor: 14.919

Review 3.  Intracellular protein degradation in mammalian cells: recent developments.

Authors:  Erwin Knecht; Carmen Aguado; Jaime Cárcel; Inmaculada Esteban; Juan Miguel Esteve; Ghita Ghislat; José Félix Moruno; José Manuel Vidal; Rosana Sáez
Journal:  Cell Mol Life Sci       Date:  2009-04-28       Impact factor: 9.261

4.  The basis for selective E1-E2 interactions in the ISG15 conjugation system.

Authors:  Larissa A Durfee; Melissa L Kelley; Jon M Huibregtse
Journal:  J Biol Chem       Date:  2008-06-26       Impact factor: 5.157

Review 5.  Ubiquitin proteasome system research in gastrointestinal cancer.

Authors:  Jia-Ling Zhong; Chang-Zhi Huang
Journal:  World J Gastrointest Oncol       Date:  2016-02-15

6.  Shared and unique properties of ubiquitin and SUMO interaction networks in DNA repair.

Authors:  Sjoerd J L van Wijk; Stefan Müller; Ivan Dikic
Journal:  Genes Dev       Date:  2011-09-01       Impact factor: 11.361

7.  The ubiquitin-like modifier FAT10 stimulates the activity of deubiquitylating enzyme OTUB1.

Authors:  Johanna Bialas; Annika N Boehm; Nicola Catone; Annette Aichem; Marcus Groettrup
Journal:  J Biol Chem       Date:  2019-02-04       Impact factor: 5.157

Review 8.  The ubiquitin proteasome system and myocardial ischemia.

Authors:  Justine Calise; Saul R Powell
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-12-07       Impact factor: 4.733

9.  A novel type of E3 ligase for the Ufm1 conjugation system.

Authors:  Kanako Tatsumi; Yu-shin Sou; Norihiro Tada; Eri Nakamura; Shun-ichiro Iemura; Tohru Natsume; Sung Hwan Kang; Chin Ha Chung; Masanori Kasahara; Eiki Kominami; Masayuki Yamamoto; Keiji Tanaka; Masaaki Komatsu
Journal:  J Biol Chem       Date:  2009-12-14       Impact factor: 5.157

Review 10.  Cullin-RING Ligases as attractive anti-cancer targets.

Authors:  Yongchao Zhao; Yi Sun
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.